Kimberly-Clark to Buy Tylenol Maker Kenvue for $40 Billion

Kimberly-Clark Corp. agreed to buy struggling Tylenol maker Kenvue Inc. in a deal worth roughly $40 billion.

By Redd Brown · Bloomberg Markets

Kimberly-Clark Corp. agreed to buy struggling Tylenol maker Kenvue Inc. in a deal worth roughly $40 billion.